Authors: BACUS S KIFFMEYER B GUDKOV A KEYOMARSI K

Citation: S. Bacus et al., HEREGULIN AND DOXORUBICIN ACTIVATE A P53 DEPENDENT PATHWAY IN CANCER-CELLS WHEREAS TAXOL DEPENDS ON ACTIVATION OF THE MAP KINASE PATHWAY, European journal of cancer, 34, 1998, pp. 134-134

Authors: BACUS SS YARDEN Y GUDKOV A KEYOMARSI K

Citation: Ss. Bacus et al., NEU DIFFERENTIATION FACTOR (HEREGULIN) ACTIVATES A P53-DEPENDENT PATHWAY IN CANCER-CELLS, Laboratory investigation, 76(1), 1997, pp. 71-71

Authors: GARKAVTSEV I KAZAROV A GUDKOV A RIABOWOL K

Citation: I. Garkavtsev et al., SUPPRESSION OF THE NOVEL GROWTH INHIBITOR P33(ING1) PROMOTES NEOPLASTIC TRANSFORMATION, Nature genetics, 14(4), 1996, pp. 415-420

Authors: BACUS SS YARDEN Y OREN M CHIN DM LYASS L ZELNICK CR KAZAROV A TOYOFUKU W GRAYBABLIN J BEERLI RR HYNES NE NIKIFOROV M HAFFNER R GUDKOV A KEYOMARSI K

Citation: Ss. Bacus et al., NEU DIFFERENTIATION FACTOR (HEREGULIN) ACTIVATES A P53-DEPENDENT PATHWAY IN CANCER-CELLS, Oncogene, 12(12), 1996, pp. 2535-2547